Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11312433Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$5.1M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#1,370
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Alon Singer as a PI. Multi-PI records show the full award amount for context.
- 5R44AI136064-06R44Direct-from-specimen identification of pathogens common in endocarditis$1Maward amount
- 5R44AI186712-02R44An automated culture-free system for the identification of bloodstream infections direct from blood$1Maward amount
- 5SB1AI183963-02SB1Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.$1Maward amount
- 5SB1AI172440-03SB1Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis$1Maward amount
- 5R44AI174578-03R44Diagnostic tool for assessment and tracking of microbial load in bloodstream infections$996.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Alon Singer as a PI.
FY2025 award administered by Helixbind, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHelixbind, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #508
- 2024Entered Top 25% NationallyRanked #508
- 2024Entered Top 10% NationallyRanked #508
- 2024Entered Top 5% NationallyRanked #508
- 2025$10M Cumulative Funding